Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02335567 · ClinicalTrials.gov registry record
Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms
A clinical trial of Carotid Plaque Hemorrhage Appearance, sponsored by Michigan State University.
- Completed
- Registry status
- 162
- Enrollment target
- 1
- Study location
NCT02335567 is a study of Carotid Plaque Hemorrhage Appearance that has completed, run by Michigan State University. The registered enrollment target is 162 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02335567, a study of Carotid Plaque Hemorrhage Appearance, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare two competing newly designed 3D sequences for black blood carotid plaque imaging techniques with the industry standard 2D sequnce for black blood.
Conditions Studied
Interventions
- OTHER there is no intervention
Study Locations (1)
Michigan
- Michigan State University - Department of Radiology - East Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02335567
The ClinicalTrials.gov registry entry for NCT02335567 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carotid Plaque Hemorrhage Appearance appearing as the primary indexed condition, and to 1 intervention - of which there is no intervention is the first listed.
NCT02335567 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02335567 about?
NCT02335567 is a clinical study titled "Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms". To compare two competing newly designed 3D sequences for black blood carotid plaque imaging techniques with the industry standard 2D sequnce for black blood.
What is the current status of trial NCT02335567?
This trial is currently completed. The enrollment target is 162 participants. The study started on 2012-06. Estimated completion is 2016-01.
What conditions does trial NCT02335567 study?
This clinical trial studies the following conditions: Carotid Plaque Hemorrhage Appearance.
What interventions are being tested in trial NCT02335567?
The interventions under investigation include: there is no intervention (OTHER).
Who is sponsoring clinical trial NCT02335567?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02335567 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.